Article Sidebar

pdf
Date Published: 09/07/2024
Online Published: 31/08/2023
Abstract Views: 157
Views pdf: 39
DOI: https://doi.org/10.55046/vjrnm.52.909.2023
Issue
No. 52 (2023)
Section
Scientific research
How to Cite
Le, T. B. (2023). ENDOVASCULAR MANAGEMENT OF THE LOWER EXTREMITY DEEP VEIN THROMBOSIS. Vietnamese Journal of Radiology and Nuclear Medicine, 52, 10-18. https://doi.org/10.55046/vjrnm.52.909.2023

ENDOVASCULAR MANAGEMENT OF THE LOWER EXTREMITY DEEP VEIN THROMBOSIS

Le Trong Binh1,
1 

Main Article Content

Abstract

Lower extremity deep vein thrombosis (LEDVT) is a common vascular disease which may cause life-threatening complications such as pulmonary embolism or lead to lifelong sequelae such as post-thrombotic syndrome. Anticoagulation remains the standard treatment of LEDVT endorsed by various international practice guidelines. However, anticoagulation alone is usually inadequate in the setting of large thrombus burden (iliofemoral DVT), extensive LEDVT (inferior vena cava extension) and venous outflow obstruction (eg, May-Thurner syndrome), therefore increases the risk of delayed symptom alleviation, thrombus recurrence and disease progression. Prompt diagnosis and timely intervention including effective thrombus exclusion and venous outflow recanalization are crucial in optimizing treatment outcomes, limiting complications, and preventing further sequalae. Recently, endovascular approach has shown advantages over open surgery and medical treatment in selected population of LEDVT. This minimally invasive technique includes a single-session and step-by-step intervention combining an inferior vena cava filter insertion, catheter-directed thrombolysis, mechanical thrombectomy and iliocaval recanalization by venoplasty and/or stenting. This paper aims to provide an insight into the current status of endovascular treatment of LEDVT and experience from a single center.

Article Details

Keywords

deep vein thrombosis, thrombolysis, thrombectomy, endovascular, May-Thurner syndrome

References

1. Di Nisio M, van Es N, Buller HR. Deep vein thrombosis and pulmonary embolism. Lancet. 2016;388(10063):3060-73.
2. Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet. 2021;398(10294):64-77.
3. Kim KA, Choi SY, Kim R. Endovascular Treatment for Lower Extremity Deep Vein Thrombosis: An Overview. Korean J Radiol. 2021;22(6):931-43.
4. Goldhaber SZ, Magnuson EA, Chinnakondepalli KM, Cohen DJ, Vedantham S. Catheter-directed thrombolysis for deep vein thrombosis: 2021 update. Vasc Med. 2021;26(6):662-9.
5. Mazzolai L, Aboyans V, Ageno W, Agnelli G, Alatri A, Bauersachs R, et al. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. Eur Heart J. 2018;39(47):4208-18.
6. Ashrafi M, Ahmad SB, Antoniou SA, Khan T, Antoniou GA. Treatment Strategies for Proximal Deep Vein Thrombosis: A Network Meta-analysis of Randomised Controlled Trials. Eur J Vasc Endovasc Surg. 2022;63(2):323-34.
7. Desai KR. Endovascular Management of Acute Iliofemoral Deep Vein Thrombosis: Who Benefits? J Vasc Interv Radiol. 2022;33(10):1171-2.
8. Huang T, Ding W, Chen Z, Yin Y, Yu J, Jin Y, et al. Comparison of Pharmacomechanical Catheter-Directed Thrombolysis versus Catheter-Directed Thrombolysis for the Treatment of Acute Iliofemoral Deep Vein Thrombosis: Measures of Long-Term Clinical Outcome and Quality of Life. Ann Vasc Surg. 2021;76:436-42.
9. Comerota AJ, Kearon C, Gu CS, Julian JA, Goldhaber SZ, Kahn SR, et al. Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis. Circulation. 2019;139(9):1162-73.
10. Vedantham S, Sista AK, Klein SJ, Nayak L, Razavi MK, Kalva SP, et al. Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol. 2014;25(9):1317-25.
11. Kaufman JA, Barnes GD, Chaer RA, Cuschieri J, Eberhardt RT, Johnson MS, et al. Society of Interventional Radiology Clinical Practice Guideline for Inferior Vena Cava Filters in the Treatment of Patients with Venous Thromboembolic Disease: Developed in collaboration with the American College of Cardiology, American College of Chest Physicians, American College of Surgeons Committee on Trauma, American Heart Association, Society for Vascular Surgery, and Society for Vascular Medicine. J Vasc Interv Radiol. 2020;31(10):1529-44.
12. Le TB, Lee TK, Park KM, Jeon YS, Hong KC, Cho SG. Contralateral Deep Vein Thrombosis after Iliac Vein Stent Placement in Patients with May-Thurner Syndrome. J Vasc Interv Radiol. 2018;29(6):774-80.
13. Enden T, Haig Y, Klow NE, Slagsvold CE, Sandvik L, Ghanima W, et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012;379(9810):31-8.
14. Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, et al. Pharmacomechanical CatheterDirected Thrombolysis for Deep-Vein Thrombosis. N Engl J Med. 2017;377(23):2240-52.
15. Fujioka S, Kitamura T, Shikata F, Mishima T, Onishi Y, Araki H, et al. Outcomes after Rivaroxaban Treatment of Extensive Deep Vein Thrombosis. Ann Vasc Surg. 2022;85:246-52.
16. Strijkers RH, de Wolf MA, Wittens CH. Risk factors of postthrombotic syndrome before and after deep venous thrombosis treatment. Phlebology. 2017;32(6):384-9.
17. Appelen D, van Loo E, Prins MH, Neumann MH, Kolbach DN. Compression therapy for prevention of postthrombotic syndrome. Cochrane Database Syst Rev. 2017;9(9):CD004174.
18. Visona A, Quere I, Mazzolai L, Amitrano M, Lugli M, Madaric J, et al. Post-thrombotic syndrome. Vasa. 2021;50(5):331-40.